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Resting Myoplasmic Free Calcium in Frog Skeletal Muscle Fibers
Estimated with Fluo-3
A. B. Harkins, Nagomi Kurebayashi,* and S. M. Baylor
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085 USA
ABSTRACT Fluo-3 is an unusual tetracarboxylate Ca2+ indicator. For recent lots supplied by Molecular Probes Inc. (Eugene,
OR), FMAx, the fluorescence intensity of the indicator in its Ca2+-bound form, is -200 times that of FMIN, the fluorescence
intensity of the indicator in its Ca2+-free form. (For earlier lots, impurities may account for the smaller reported values of
FMAx/FMIN, 36-40). We have injected fluo-3 from a high-purity lot into intact single fibers from frog muscle and measured the
indicator's absorbance and fluorescence signals at rest (A and F, respectively) and changes in absorbance and fluorescence
following action potential stimulation (AA and AF, respectively). As for other high-affinity Ca2+ indicators used previously in frog
muscle, the time course of the indicator's AA and AF signals substantially lagged behind that of the myoplasmic free Ca2+
transient. Our analysis of fluo-3's signals from myoplasm therefore focused on information about the level of resting myoplasmic
free [Ca2+] ([Ca2']r).
From/A, AA, and in vitro estimates of fluo-3's molar extinction coefficients, the change in the fraction of fluo-3 in the Ca2+-bound
form during activity (Af) was estimated. From Af, AF, and F, the fraction of the indicator in the Ca2+-bound form in the resting
fiber (fr) was estimated by fr = (Af x F/AF) + (1 - FMAx/FM1N)-1 . Since FMAx/FMIN is large, the contribution of the second term
to the estimate of fr is small. At 160C, the mean value (mean ± S.E.) of fr was 0.086 ± 0.004 (N = 15). From two estimates
of the apparent dissociation constant of fluo-3 for Ca2+ in the myoplasm, 1.09 and 2.57 pM, the average value of [Ca2I]r is
calculated to be 0.10 and 0.24 MM, respectively. The smaller of these estimates lies near the upper end of the range of values
for [Ca2+]r in frog fibers (0.02-0.12 MM) estimated by others with aequorin and Ca2+-selective electrodes. The larger of the
estimates lies within the range of values (0.2-0.3 pM) previously estimated in this laboratory with fura red. We conclude that
[Ca2 ]r in frog fibers is at least 0.1 ,M and possibly as large as 0.3 MM.
INTRODUCTION
A recent article from this laboratory (1) described the use of
the Ca2" indicator fura red (2) to estimate the resting level
of myoplasmic free [Ca2+] ([Ca2+Ir) in intact frog skeletal
muscle fibers. The value estimated, 0.2-0.3 ,M, is higher
than the 0.02-0.12 ,uM range previously estimated with ae-
quorin and Ca2+-selective microelectrodes (Ref. 3 and other
references cited in Ref. 1). Our goal here was to see if fluo-3
(4), an indicator that produces a very large increase in flu-
orescence intensity upon complexation with Ca2 , might
also be used to estimate [Ca2+]r. Since neither the excitation
nor emission spectrum of fluo-3 changes substantially with
Ca21 complexation, it is not possible to calibrate this indi-
cator's signal by commonly employed "ratiometric" proce-
dures, e.g., those used with indo-1 and fura-2 (5). Moreover,
since the fractional change in fluo-3's absorbance spectrum
with Ca2+ complexation is small, calibration by the proce-
dure developed for fura red in frog fibers (1), which utilizes
information in the shape of the indicator's resting absorbance
spectrum, is also not possible.
We report here a novel calibration procedure for estima-
tion of [Ca21]. with fluo-3. The method relies on the meas-
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urement of the indicator's absorbance and fluorescence sig-
nals in a fiber at rest (signals denotedA and F, respectively)
and changes in these signals following electrical stimulation
(AA and AF). From these four in vivo measurements, from
in vitro estimates of the indicator's molar extinction coef-
ficients in its Ca2"-free and Ca2"-bound forms, and from an
assumed value for FMAX/FMIN (the ratio of the fluorescence
intensity of Ca2"-bound fluo-3 to that of Ca2+-free fluo-3),
it is possible to estimatefr, the fraction of fluo-3 in the Ca2+-
bound form at rest. Because the value of FMAX/FMIN in my-
oplasm is likely to be large (alOO), the estimate of fr is not
very sensitive to the exact value assumed for FMAX/FMIN.
In these experiments, which utilized a nonperturbing con-
centration of indicator (s 0.2 mM), the average value esti-
mated for fr was 0.086 (± 0.004, mean + S.E.; N = 15;
16°C). From two estimates of fluo-3's dissociation constant
for Ca2+ in the myoplasmic environment, 1.09 and 2.57 ,uM,
the corresponding estimates of [Ca2]]rare 0.10 and 0.24 ,uM.
The smaller of these estimates falls near the upper end of the
range of [Ca21]r (0.02-0.12 ,uM) previously obtained with
the other techniques, while the larger of the estimates agrees
with our estimates obtained with fura red, 0.2-0.3 ,uM (1).
The results support the conclusion that [Ca21]r is likely to be
at least 0.1 ,uM and possibly as large as 0.3 ,uM.
Some of the results have been presented previously in
abstract form (6-8).
METHODS
The penta-ammonium salt of fluo-3 was obtained from Molecular Probes,
Inc. (Eugene, OR) and stored in a freezer until use, when a stock solution
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of 10-30 mM fluo-3 in distilled water was prepared. For the in vitro meas-
urements, this solution was diluted into the various buffer solutions to a final
concentration of 0.01-0.1 mM. For the in vivo measurements, the stock
solution itself was pressure-injected into single muscle fibers. With lot
1OB-1 (an early lot of fluo-3 from Molecular Probes), the value of FMAX/
FMIN measured in vitro was -40, as expected from the report of Minta et
al. (4). With a more recent lot (lot 1OD-1), however, FMAx/FMIN was much
larger, -200 (see Results). Chemical analysis indicated that the purity of lot
10D-1 was high: -95% of the total absorbance of a sample (measured at
500 nm) eluted as a single peak when analyzed by liquid chromatography
(Waters HPLC System; Milford, MA). Unless indicated otherwise, all meas-
urements reported in Results were carried out with lot 1OD- 1. The methods
used were similar to those previously described (1, 9) and are summarized
below. All measurements, both in vitro and in vivo, were carried out at
16-170C.
In vitro measurements
Solutions
Buffer alone. A standard buffer solution was used to characterize the
basic absorbance and fluorescence properties of fluo-3. This solution con-
tained (in millimolar): 97.7 KCI, 10 PIPES (piperazine-N,N'-bis(2-
ethanesulfonic acid)) and either 10 EGTA (ethyleneglycol-bis(,B-aminoethyl
ether)-N,N,N',N'-tetraacetic acid), which was used for the Ca2l-free cali-
bration solution ("0 Ca2+" solution), or 10 CaC12, which was used for the
saturating-Ca21 calibration solution ("sat. Ca2+" solution). The ionic
strength was 0.15 M and, unless indicated otherwise, the pH was 7.03.
Buffer plus sucrose. To characterize effects of solution viscosity
(reported in centipoise, cP), measurements were made in the standard buffer
with either no added sucrose (viscosity = 1.1 cP) or with 0.632 M sucrose
(viscosity = 2.2 cP, referred to hereafter as the 2 cP buffer solution). The
viscosity of these solutions at 160C was estimated from standard tables.
Buffer plus aldolase. To characterize possible effects of myo-
plasmic proteins, measurements were made in buffer solution containing
aldolase, the most abundant soluble myoplasmic protein on a weight basis
(10). Rabbit aldolase (type "X," molecular weight 160,000, lots 40H9570
and 120H9500; Sigma Chemical Co., St. Louis, MO) was prepared as de-
scribed previously (1, 9) and used at concentrations between 0 and 122
mg/ml. In some experiments, solution viscosity was maintained approxi-
mately constant (at 2 cP) as the aldolase concentration was increased, by
proportional reductions in the sucrose concentration. The viscosity of these
solutions was estimated from previous calibrations (9), carried out with an
Ostwald-type viscometer, on solutions of similar composition.
Optical measurements
Absorbance. In vitro absorbance spectra of 10-20 l±M Fluo-3 were
measured in a spectrophotometer (Ultraspec 4050; LKB Instruments, Gaith-
ersburg, MD) at wavelengths A between 400 and 600 nm (in 2-nm incre-
ments). The spectra were later interpolated to 1-nm resolution and filtered
by an 11-point smoothing routine that averaged absorbance over 11 adjacent
wavelengths. The filtered curves could then be compared with the fiber
absorbance measurements (see below), which were made with interference
filters that had a 10-nm bandpass (Omega Optical Co., Brattleborough, VT).
In the standard buffer solution (1.1 cP), the isosbestic wavelengths for Fluo-
3's reaction with Ca21 were found to be 503 and 530 nm. The molar ex-
tinction coefficient at 503 nm (E503) was estimated to be 8.19 x 104 M-'
cm-' from the following information: (a) the value of E506, 8.35 x 104 M-'
cm-', given by Minta et al. (4) for the Ca2l-bound form of Fluo-3 in a
solution of similar viscosity and (b) the ratio of absorbances at 503 and 506
nm measured from Fluo-3's sat. Ca21 spectrum. This value of E503 was then
used as a standard for calculation of molar extinction coefficients at other
wavelengths and under other solution conditions (see below).
Fluorescence. Quartz capillaries (internal diameter, 150-230 Am;
Vitro Dynamics, Rockaway, NJ) were filled with buffer solution containing
0.06-0.10 mM Fluo-3 and mounted on the horizontal optical bench appa-
ratus used for the muscle fiber experiments (11). Fluorescence was excited
with light of wavelength 480 ± 15 nm, selected by an interference filter
(RDF480 filter; Omega Optical Co.) positioned between the 100-W
tungsten-halogen source and the capillary. Emission wavelengths greater
than 510 nm were selected by a barrier filter (REF510; Omega Optical Co.)
placed between the capillary and the silicon diode (UV100; EG&G, Salem,
MA) used to measure light intensity. In all cases the reported Fluorescence
intensities (F) have been corrected for a small component ofnonFluorescent
light ("cross-talk" intensity) that arose because of an overlap in the band-
pass of the excitation and emission filters.
Inner filter effect calculations. Calculations of the type de-
scribed in Ref. 1 were made to check whether, as a result of the inner filter
effect (12), the ratio FMAX/FMIN is expected to vary significantly with the
concentration of Fluo-3. The calculations indicated that variations in FMAX/
FMIN should be small (c 1%) at the principal indicator concentrations used
in this paper (in vitro, 0.1 mM; in vivo, < 0.2 mM). Experimental checks,
at Fluo-3 concentrations between 0.01 and 0.3 mM, confirmed that this was
the case. Therefore corrections of the type made for fura red (1) were not
made for Fluo-3.
Fluorescence emission anisotropy. The anisotropy (denoted
a) of Fluo-3's Fluorescence emission was measured in the manner described
for fura-2 (9) and fura red (1). As expected, a for Fluo-3 was found to be
essentially the same whether the excitation beam was linearly polarized
parallel or perpendicular to the long axis of the capillary (anisotropy val-
ues denoted ao and a90, respectively); hence, the values of a reported in
Results are the average of ao and ago. To estimate the "limiting anisot-
ropy" of Fluo-3 in a solution of "infinite" viscosity, measurements of a
were made at solution viscosities between 1.1 and 30 cP (sucrose concen-
trations between 0 and 1.975 M; cf. Ref. 9) and analyzed by means of a
Perrin plot (cf. Refs. 9 and 12).
Estimation of K,. Fluo-3's apparent dissociation constant for Ca21
(KD) was estimated from measurements of the Fluorescence intensity of
capillary solutions that contained the same concentration of Fluo-3 (0.10
mM) but different concentrations of free Ca21 ([Ca2+]). The latter values
(reported in pCa units) were set by a Ca2+-EGTA buffer system (1). The
intensity data were fitted by the equation for 1:1 binding:
[Ca2+]
J [Ca2+] + KD (1)
with KD taken as an adjustable parameter. For each [Ca2"] level, f, the
fraction of Fluo-3 in the Ca2+-bound form, was calculated from the
measured value of F by the equation f = (F - FMN)/(FMA - FMIN) (cf.
Fig. 4 A).
In vivo measurements
Adult frogs (Rana temporaria; Charles Sullivan, Nashville, TN) of both
sexes were obtained during all seasons of the year and kept in a refrigerator
at 4°C. The time spent in the cold before use was typically 2-4 weeks (range,
1-8 weeks). Single twitch fibers from iliofibularis or semitendinosus muscle
were dissected in a normal Ringer solution (120 mM NaCl, 2.5 mM KCI,
1.8 mM CaC12, 5 mM PIPES; pH 7.1). An isolated fiber was mounted on
the optical bench apparatus, stretched to a long sarcomere length (3.64.0
,um) and lowered onto pedestal supports to minimize movement artifacts in
the optical records. Fluo-3 was pressure-injected into the myoplasm after
impalement of the fiber by a glass micropipette (tip resistance, -5 Mfl, if
filled with 3 M KCI). In many experiments the injection of indicator pro-
ceeded slowly at the pressure most-commonly used (- 10p.s.i.) and, in these
experiments, injections took up to 15 min to complete. The volume of fluid
injected was typically quite small, less than 10 pL, as calculated from the
concentration of indicator in the pipette and the profile of indicator con-
centration measured along the fiber axis. Swelling ofthe fiber at the injection
site was generally not observed.
In some experiments, the normal Ringer solution was exchanged for a
"high-Ca2+" Ringer that contained 11.8 rather than 1.8mM CaCl2. The high
Ca2' Ringer appeared to reduce the likelihood of impalement damage that
sometimes resulted from the microinjection of indicator (cf. Ref. 13). In
three experiments, the normal Ringer solution was exchanged for Ringer
containing an elevated concentration of potassium, 5-12.5 mM. In these
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experiments, the NaCl was partially replaced with Na+-proprionate so that
the KCl product, and the ionic strength of the Ringer remained approxi-
mately constant (cf. Ref. 3).
Criteria for a successful injection. To assess possible fiber
damage related to the injection of indicator, the fiber's intrinsic birefrin-
gence signal in response to action potential stimulation ("second compo-
nent" described in Ref. 14) was measured before and after the injection. A
fiber was not included in the analysis unless its birefringence signal was of
normal appearance (fractional change in light intensity, a 0.001; time to
peak, 8-10 ms) and essentially unchanged as a result of the injection. A
second assessment of injection damage, carried out immediately after com-
pletion of the injection, came from a visual inspection of Fluo-3's resting
Fluorescence. In many fibers, a small region of slightly elevated Fluores-
cence was detected within a 10-20 ,um radius of the impalement site; a fiber
of this type usually had a normal birefringence signal and, if so, was included
in the anaylsis. Afew fibers, however, had a larger, more intense and, in some
cases, irregular Fluorescence at the impalement site; fibers of this type were
assumed to have suffered significant damage as a result of the injection and
were excluded from the analysis. In general, the principal optical measure-
ments were made at a location slightly removed from the injection site (e.g.,
50-150 ,um along the fiber axis) to minimize the possible influence of
injection damage on the estimates of [Ca21]r.
Absorbance measurements. Following a successful injection,
a small region of the fiber was transilluminated with a spot of light (diameter,
43-73 gm) for the measurement of fiber absorbance. The measurements and
analysis were carried out at a series of wavelengths (480-630 nm, A in-
crements of 10-30 nm), selected by interference filter (1). The raw mea-
surements were corrected for the estimated contribution of the fiber's in-
trinsic absorbance to obtain the indicator-related absorbance (denoted A(A);
cf. Fig. 5). From A(A), Beer's law was used to estimate the myoplasmic
concentration of indicator (denoted [DT]). For this purpose the A(A) data
were fitted with the indicator's absorbance spectrum measured in a 0 Ca21
solution. As described in Results, good fits ofA(A) were not obtained unless
the in vitro spectrum was shifted along the wavelength axis. For the esti-
mation of [DT], the following molar extinction coefficients (e) and corre-
sponding isosbestic wavelengths (AiO; referenced to the unshifted wave-
length axis) were obtained from the in vitro spectra: (i) for the 2 cP solution
with no added protein ("0 aldolase" condition): Ai,, = 504 nm and E504 =
7.83 X 104 M-1 Cm-1; (ii) for the "saturating" aldolase condition (see Re-
sults): Ai,, = 515 nm and E515 = 6.99 x 104 M-1 cm-'. The myoplasmic
path length was estimated as previously described (15).
The change in fiber absorbance in response to action potential stimulation
(AA(A)) was also measured (1). Interestingly, the AA(A) measurements con-
tained clearly resolved information about the change in concentration of
Ca2+-Fluo-3 complex. Thus, the AA(A) measurements provided the addi-
tional piece of information required to calibrate the indictor's in vivo signals
in terms of absolute [Ca2+] levels (see following paragraphs). Information
sufficient for calibration was not available from the resting A(A) measure-
ments because, in our apparatus, two sources of noise rendered unresolvable
any potential information about the resting concentration of Ca2+-Fluo-3
complex: (i) the noise introduced by the correction for the fiber's intrinsic
absorbance (cf Fig. 5) and (ii) the noise resulting from fluctuations in
lamp intensity that occur on a time scale of several minutes (the time
scale required to record the reference intensity levels needed for calcula-
tion of A(A)).
As for A(A), AA(A) was not well-fitted by an in vitro Ca2+-difference
spectrum unless the difference spectrum was shifted along the wavelength
axis. From AA(A), Beer's law was used to estimate A[CaD], the change in
concentration of Ca2+-Fluo-3 complex. For this calculation, changes in the
indicator's molar extinction coefficient (AE) were estimated at two wave-
lengths near the positive and negative peaks of the difference spectrum; the
estimation of A[CaD] relied on the difference in the two AE values, as
follows: (i) for the 0 aldolase (2 cP) condition: AE515 - AE493 = 2.50 x 10"
M-1 cm-,; (ii) for the saturating aldolase condition: AE527 AE501 = 1.86
X 104 M-' cm-'. From the measurements of A(A) and AA(A), the change
in the fraction of Fluo-3 in the Ca2l-bound form (Af) was estimated as:
Af A[CaD]/[DTI-
Fluorescence measurements. The Fluorescence intensity (F)
of Fluo-3 in a resting fiber was measured with the same filters used for the
capillary measurements. A vertical slit was usually inserted into the light
path to restrict the excitation beam to an axial length of fiber of -70 Jim.
As for the in vitro measurements, the F measurements were corrected for
the cross-talk component of intensity. This component was estimated from
a region of fiber, distant from the injection site, that did not contain indicator.
The change in Fluo-3 Fluorescence in response to action potential stimu-
lation (AF) was also measured. Since resting F was always measured just
prior to stimulation, the fractional change in Fluorescence (AF/F) could be
calculated.
Estimation of fr. If Fluo-3 exists in myoplasm in one of two states,
Ca2l-free or Ca2l-bound, then F is related tOfr, the fraction of the indicator
in the Ca2l-bound form at rest, by:
F = FMIN + f,(FMAX- FMIN) (2)
Here, FMIN and FmAx denote the intensity levels that would be measured
if all the indicator molecules in the measurement region were either Ca2+-
free or Ca2+-bound, respectively. Similarly, AF is related to Af by:
AF = Af(FMAX FMIN)- (3)
Hence:
fr = Af(F/AF) + (1 - FMAX/FMIN)- 1- (4)
Since Af = A[CaD]/[DT] (see above), fr can be calculated from the mea-
surements ofA, AA, F, AF, and an assumed value for FmAx/FMN. IfFMAx/
FMIN iS large (e.g., in the range 100-200, see Results), the value estimated
for fr is not very sensitive to the exact value assumed for FMAx/FMIN-
For Equation 4 to be accurate, the absorbance and Fluorescence mea-
surements must be made from the same fiber region and referred to the same
point in time. The optical measurements were therefore made as follows: (i)
AF/F was measured first. (ii) Then A(A) and AA(A) were measured se-
quentially at five to eight wavelengths between 480 and 630 nm; these
measurements were made within the same 70-,um length of fiber used for
the Fluorescence measurements and included appropriate bracketing at one
or two wavelengths, usually 510 and/or 520 nm. (iii) AF/F was again meas-
ured. In the analysis stage, the A(A) and AA(A) data were corrected by
interpolation for any small changes in indicator concentration during the run,
and the corrected data were compared with the average of the two mea-
surements of AF/F. The AF/F amplitudes usually differed by 5-10% (range
0-20%). With each absorbance or Fluorescence measurement in the run, the
fiber region received 2-3 s of illumination; the interval between stimulated
action potentials was -30 s.
Statistics. Results from more than two experiments are reported as
mean value ± standard error (mean ± SE). Student's two-tailed t test, with
p < 0.05, was used to determine the statistical significance of a difference
between means.
RESULTS
Part 1: In vitro measurements
Effects of illumination
To determine whether Fluo-3 was altered by the light inten-
sities available on our apparatus (cf. Ref. 4), capillaries con-
taining the indicator were illuminated continuously with 480
(± 15)-nm light for a period of 10 min, and the values ofF
measured after 5 and 10 min of illumination were com-
pared with the preillumination level. With the first 5 min
of illumination, FMIN and FMAX decreased by 11 and 18%,
respectively, and, with the second 5 min of illumination,
by a further 0 and 6%, respectively. For the 10-min period,
the ratio of FMAX/FMIN decreased, on average, at a rate of
-1.5%/min compared with the preillumination value.
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Since, in the in vivo measurements, runs were usually
completed with less than 30 s of total illumination (e.g.,
5-10 measurements, with 2-3 s of illumination per meas-
urement), alterations in Fluorescence due to illumination
during the run are not likely to have been significant.
Effects of viscosity
Although the viscosity of myoplasm is not known precisely,
it is probably about twice that of water (2 vs. 1 cP at 20°C
(16)). Since a doubling of viscosity was shown to affect
somewhat the properties of fura-2 (5, 9, 17) and fura red (1),
it was of interest to investigate possible effects of viscosity
on Fluo-3.
Absorbance. Absorbance spectra of Fluo-3 were very
similar when measured at solution viscosities of 1.1 cP (not
shown) and 2 cP (cf. Fig. 1). At the higher viscosity, there
appeared to be a small (1-2 nm) red shift in both the 0 Ca2+
and sat. Ca21 spectra, with little change (<5%) in spectral
amplitude.
Fluorescence. An increase in solution viscosity from 1.1
to 2 cP produced a 19% increase in FMIN, a 3% increase in
FMAX, and a 13% decrease in FMAX/FMIN, from 185 to 161.
A.
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FIGURE 1 In vitro absorbance spectra of 20 ,M Fluo-3 measured in a
spectrophotometer (solution viscosity of 2 cP, set with sucrose). (A) Ab-
solute spectra in 0, and sat. Ca2l solutions. (B) The Ca2l difference spec-
trum (sat. Ca2e minus 0 Ca2") from A, plotted on expanded vertical scale.
Effects of Ca2-
Absorbance. Fig. 1 A shows absorbance spectra of
Fluo-3 in its Ca2"-free and Ca2"-bound forms. With Ca2"
complexation, there is a red-shift of -3 nm in the location
of the peak absorbance and a slight increase in the amplitude
of the peak. Fig. 1 B shows the Ca2" difference spectrum on
expanded vertical scale. This spectrum has an unusual
"triphasic" shape, with isosbestic wavelengths at 504 and
535 nm (in a 2-cP solution). Although the fractional change
of Fluo-3's absorbance with Ca21 complexation is small, the
change is sufficiently large that duplicate measurements of
the difference spectrum yielded the same basic shape (cf. the
continuous trace in Fig. 2 E, described below).
Fluorescence. Minta et al. (4) report that the Fluores-
cence intensity ofFluo-3 increases -40-fold with Ca2+ com-
plexation (FMAx/FMIN = 36-40). We observed a similar in-
crease for an early sample of Fluo-3 purchased from
Molecular Probes (lot lOB-l), in which FMAX/FMIN was -45
(part A of Table 1). However, for lot lOD- (part B of Table
1), FMkx/FMN was much larger, -200. When samples from
the two lots were examined in parallel measurements at nom-
inally identical concentrations, FMAX of lot lOD- 1 was about
1.4 times that of lot lOB-1, whereas FMIN of lot lOD-1 was
only one-third that of lot lOB-1. Thus, the nearly 5-fold
change in the value of FMAX/FMIN may have been due to a
fluorescent contaminant (perhaps a Ca2+-insensitive one)
that was present at larger concentration in lot lOB-1. Because
a larger value of FMAX/FMIN reduces the uncertainty in the
estimate offr (cf. Equation 4), lot 1OD-1 was routinely used
for the measurements of this paper.
Effects ofpH
Minta et al. (4) report that, ifpH is lowered from 8 to 6, FMAX
remains approximately constant, while FMIN increases by a
factor slightly less than 2. Table 1 lists values of FMAX and
FMIN at three levels of pH (6.8, 7.0, and 7.5) for the two lots
of Fluo-3. The variations in FMAX and FMIN with pH are
about as expected from the earlier report (4). For apH change
from 7.5 to 6.8, the increase in FMIN was somewhat greater
for lot 1OD-l than for lot lOB-I (relative changes of 46 and
22%, respectively). With lot 1OD-l, the average value of
FMAX/FMIN measured at all pH values was large, 188-283.
Effects of aldolase
In the case of fura-2 (9, 18) and fura red (1), indicator prop-
erties were altered substantially if soluble muscle proteins
were added to the calibration solutions at a concentration
similar to that of the soluble protein concentration in myo-
plasm, 50-90 mg/ml (10). It was therefore of interest to de-
termine whether similar effects occurred with Fluo-3. As be-
fore, aldolase, the most abundant soluble protein in
myoplasm on a weight basis (10), was chosen as a repre-
sentative protein for these measurements.
Absorbance. PanelA of Fig. 2 shows absorbance spectra
of Fluo-3 in a 0 Ca21 solution in the absence and presence
of 55 mg/ml aldolase. Aldolase caused a red-shift of -5 nm
I
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FIGURE 2 Left-hand side (viscosity = 1.6
cP): absorbance spectra of 20,LM Fluo-3 in the
absence, and presence of 55 mg/ml aldolase.
(A) 0 Ca21 spectra; (C) sat. Ca21 spectra; (E)
Ca2' difference spectra. Right-hand side (vis-
cosity = 2 cP): absorbance spectra of 20 ,uM
Fluo-3 in the aldolase-free and aldolase-bound
("saturating aldolase") forms. The saturating
aldolase spectra (dashed curves) were calcu-
lated for each of two conditions (0 Ca2 , panel
B; sat. Ca2 , panelD) from (i) pairs of spectra
of the type shown on the left-hand side, meas-
ured in the absence and presence of 55 mg/ml
aldolase at the corresponding Ca21 level, and
(ii) the fraction of the indicator estimated to be
protein-bound at 55 mg/ml aldolase. These
fractions were calculated from the best-fit pa-
rameters of Scheme 1 given in the text, and
were 0.735 (0 Ca21 solution) and 0.426 (sat.
Ca21 solution). Thus, for the 0 Ca21 condi-
tion (A and B), the saturating aldolase spec-
trum (Aald(A)) was calculated from the spec-
tra measured in 0 and 55 mg/ml aldolase
(spectra denoted AO(A) and A55(A), respec-
tively) by the equation: Aad(A) = (A55(A) -
0.265Ao(A))/0.735. For the sat. Ca2+ con-
dition (C and D), the saturating aldolase
spectgrum was calculated by the equation:
Aad(A) = (A55(A) - 0.574Ao(A))/0.426. The
dashed spectra shown in B and D were ob-
tained as the average of two runs, one at 1.6
cP (spectral pairs shown on the left-hand
side) and another at 2.2 cP (spectral pairs not
shown). The Ca2+ difference spectra in F are
the difference between the corresponding sat.
and 0 Ca21 spectra in B and D.
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TABLE 1 Fluo-3 Fluorescence at different values of pH
pH Fmin Fmax FmaxlFmin
A. Lot lOB-1
6.8 66.8 ± 0.3 (n = 5) 2742.2 ± 17.3 (n =5) 41.1 t 0.4 (n = 5)
7.0 59.2 t 0.7 (n = 7) 2816.8 t 7.8 (n = 7) 47.6 t 0.6 (n = 7)
7.5 54.8 ± 1.0 (n = 5) 2823.1 t 10.0 (n = 5) 51.5 ± 1.0 (n = 5)
B. Lot 1OD-1
6.8 63.9 ± 0.5 (n =3) 12,025 ± 82 (n = 3) 188.2 t 2.4 (n = 3)
7.0 57.6 t 1.7 (n = 3) 11,971 + 126 (n = 3) 207.8 t 6.1 (n = 3)
7.5 43.6 t 2.0 (n = 3) 12,329 ± 21.9 (n = 3) 282.8 t 13.1 (n = 3)
In vitro measurements were made from two lots of Fluo-3: Lot lOB-1 (A) and Lot 1OD-1 (B). Column 1 gives the values of pH examined. Columns 2 and
3 give the Fluorescence intensity measured in 0 Ca2+ and sat. Ca2, solutions, respectively (viscosity = 1.1 cP). These values are reported in arbitrary units
that are proportional to Fluorescence intensity. Column 4 gives the ratio, Fm.,/Fmin. For part A, the capillary diameter was 150 ,um and [DT] was 0.06 mM;
for part B, the capillary diameter was 200 ,um and [DT] was 0.10 mM. Fluorescence intensities in parts A and B are not comparable because of differences
in incident light intensity. All measurements within either part of the table were made from the same vial of Fluo-3. Different vials from the same lot revealed
slightly larger variations than indicated by the table. For example, for four vials from lot 1OD-1, the value of Fmax/Fmin varied between 175 and 225
(n = 8) at pH 7.0.
in the location of the peak absorbance and a reduction of reaction between Fluo-3 and aldolase at the concentrations
-8% in the amplitude of the peak. In a sat. Ca21 solution used for these measurements (20 ,uM Fluo-3, 55 mg/ml al-
(panel C of Fig. 2), the shift in the peak location was smaller dolase).
(-2 nm), whereas the decrease in amplitude was larger Fluorescence. Fluorescence intensities were measured
(- 13%). PanelE shows that the shape of the Ca2' difference in buffer solution at aldolase concentrations between 0 and
spectrum was altered markedly by 55 mg/ml aldolase. As will 122 mg/ml. For these measurements, the viscosity of all so-
be discussed shortly, the Ca2+-difference spectrum observed lutions was maintained approximately constant at 2 cP by
in the presence of aldolase reflects an incomplete binding proportional reductions in the sucrose concentration. As
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shown in Fig. 3 A, the value of FMIN (diamonds) increased
with increasing aldolase concentration, while that of FMAX
(circles) remained approximately constant or decreased
slightly. Fig. 3 B shows that FMAX/FMIN decreased from 174
in 0 mg/ml aldolase to 114 in 122 mg/ml aldolase. At aldolase
concentrations of 50-90 mg/ml, i.e., in the range of the sol-
uble protein concentration of myoplasm (10), the estimated
values of FMAX/FMIN are 140-120.
Estimation of the aldolase:Fluo-3 dissociation con-
stant. A binding reaction between Fluo-3 and aldolase is
presumed to underlie the effects observed in panels A, C, and
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E of Fig. 2 and in panels A and B of Fig. 3. It was therefore
of interest to estimate the apparent dissociation constant (K)
of the aldolase:Fluo-3 reaction. In principle, the increase in
FMIN with increasing aldolase concentration (Fig. 3 A) might
be used to estimate the value ofK in the absence of Ca2+ (cf.
Refs. 1 and 9). However, the increase in FMIN is not large and
might reflect, at least in part, the presence of contaminant
Ca21 in the aldolase. Thus, measurements of the indicator's
Fluorescence emission anisotropy (a) were used to estimate
the value of K in saturating Ca21 (Fig. 3 C).
In Fig. 3 C, a increases progressively with increasing al-
dolase concentration, an effect similar to that previously ob-
served with fura-2 (9) and fura red (1). This increase in a is
presumed to reflect a decrease in the rotational mobility of
the indicator when in the aldolase-bound form (cf. Ref. 12).
The curve in Fig. 3 C is based on a previous theory (9), which
assumes that each aldolase molecule can independently bind
up to N indicator molecules at equivalent sites characterized
by a single dissociation constant, K. For the fit in Fig. 3 C,
it was assumed that N = 3 (the value that previously gave
good fits in similar analyses carried out with fura-2 and fura-
red), that FMAX was the same whether Fluo-3 was protein-
free or protein-bound (cf. Fig. 3 A) and that aALD, the value
of a when all the indicator molecules are bound to aldolase,
was 0.30. This choice of aALD is somewhat arbitrary but was
based on the observations that: (i) the limiting anisotropy of
Fluo-3 (estimated from a Perrin plot; see "Methods") was
0.34; and (ii) the limiting anisotropy for fura-2, 0.37, was
somewhat greater than aALD for fura-2, 0.31 (9). The curve
in Fig. 3 C was then obtained by least-squares adjustment of
the value of K, the fitted value being 1378 AM.
Given this value ofK and the reactant concentrations used
for the absorbance measurements of Fig. 2, it follows that,
for the sat. Ca21 measurement (dashed curve in Fig. 2 C),
0.426 of the Fluo-3 was bound to aldolase. For the 0 Ca21
measurement (dashed curve in Fig. 2 A), the fraction of
Fluo-3 bound to aldolase can be estimated if the Ca2' dis-
sociation constants of aldolase-free and aldolase-bound in-
dicator are known. A complete reaction scheme of Ca ,
aldolase, and Fluo-3, for which these constants are estimated,
is considered below (cf. Scheme 1).
p
Ca
20 40 60 80 100
(aldolase] (mg/ml)
120 140
FIGURE 3 Fluo-3 Fluorescence signals (ordinates) measured in buffer
solution containing 100 ,uM Fluo-3 and different concentrations of aldolase
(abscissa). (A) FMIN and FMAX (diamonds and circles, respectively, in ar-
bitrary units proportional to intensity). (B) FMAx/FMIN, from the data in A.
(C) Fluorescence emission anisotropy (circles) measured in a sat. Ca2+
solution. In A and B, the data points have been connected by straight lines.
In C, the curve is a least-squares fit of the data by the theory described in
the text, whereby the dissociation constant (K) of aldolase for Ca2+-bound
Fluo-3 was estimated to be 1378 ,uM.
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Fluo-3 Signals from Muscle Fibers
Estimation of Fluo-3's apparent dissociation constant for
Ca2+
The purpose of this section was to measure the apparent KD
of Fluo-3 for Ca2" in the absence and presence of 55 mg/ml
aldolase. In both conditions, the Fluorescence intensity data
(Fig. 4 A: without aldolase (open circles); with 55 mg/ml
aldolase (filled circles)) were well-fitted by a 1:1 binding
curve (Equation 1, Methods) after KD was adjusted to give
a least-squares fit of the functional form to the data (curves
in Fig. 4 A). In the absence of aldolase, KD was 0.51 ,uM,
comparable to the 0.40 ,uM value reported previously (4) for
similar solution conditions (0.1 M KCl; 22°C; pH, 7.0-7.5).
In the presence of aldolase, the apparent KD was 2.1 times
larger, 1.09 ,M. The increase in apparent KD observed in 55
mg/ml aldolase is somewhat less than that reported for fura-2
and fura red, where KD increased by factors of 3.3 (9) and
4.4 (1), respectively.
Combined reaction of Ca2+ and aldolase with Fluo-3
Scheme 1 shows a minimal reaction scheme for the inter-
action of Ca2+, aldolase and Fluo-3 (cf. 9). Here, the un-
bound forms of Ca2+, aldolase, and Fluo-3 are denoted Ca,
P (for protein), and D (for dye), respectively; whereas Ca21:
Fluo-3 complex, aldolase:Fluo-3 complex, and Ca2+:
aldolase:Fluo-3 complex are denoted CaD, PD, and CaPD,
respectively. The dissociation constants of the four reactions
are denoted KD1, KD2, K1, and K2, as indicated.
As estimated above, KD1 = 0.51 ,uM and K1 = 1378 ,uM.
Since the law of mass action requires that K2 X KD2 = K1
X KD, (= 703 ,iM2), the Ca2+-titration data obtained in the
presence of aldolase (filled circle data in Fig. 4 A, replotted
in Fig. 4 B) can be fitted by a curve predicted from Scheme
1 with adjustment of one parameter only, either K2 or KD2.
The result of this fit is shown as the dashed curve in Fig. 4
B, carried out under the assumptions that FMAX did not
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change with the binding of Fluo-3 to aldolase, whereas FMIN
increased by a factor of 2 (cf. Fig. 3A). The best-fit estimates
were 366 for K2 and 1.92 ,uM for KD2. If the assumptions
were made that neither FMAX nor FMIN changed with protein
binding, the best-fit estimates were unchanged (fit not
shown). As expected, the effective single-site KD estimated
in the presence of 55 mg/ml aldolase (cf. dashed curve in Fig.
4 A; KD = 1.09 ptM) is intermediate between the values of
KD1 and KD2 assumed to apply to the complete reaction
scheme (cf. dashed curve in Fig. 4 B; KD1 = 0.51 tkM, KD2
= 1.92 ,uM).
The value estimated for the aldolase:Fluo-3 dissociation
constant in the absence of Ca21 (K2 = 366 ,uM) is substan-
tially larger than the analogous dissociation constant esti-
mated in related fits with fura-2 (66 ,uM (9)) and fura red (69
,iM (1)). The precise origin of this interesting difference in
K2 is unknown but is presumed to reflect the strength of the
interaction between aldolase and the indicator's chro-
mophore group (cf. Ref. 9, which concluded that the binding
of fura-2 to aldolase likely involves the chromophore por-
tion, rather than the Ca2+-chelating portion, of the molecule).
Estimation of the absorbance spectra of aldolase-bound
Fluo-3
From Scheme 1 and the values of the dissociation constants
estimated above, it follows that for the conditions of the
measurements in panels A, C, and E of Fig. 2 (55 mg/ml
aldolase and 20 ,uM Fluo-3), 0.735 of Fluo-3 was bound to
aldolase in the 0 Ca21 solution and 0.426 of Fluo-3 was
bound to aldolase in the sat. Ca21 solution. Given these frac-
tions, the pairs of absorbance spectra measured in Fig. 2, A
and C, may be used to calculate the absorbance spectra of
aldolase-bound Fluo-3 in the 0 and sat. Ca21 conditions (see
legend of Fig. 2). These spectra are shown as the dashed
curves in panels B and D of Fig. 2; the associated Ca21
B.
* aldolase
8 7 6 5 4 3 9 8 7 6 5 4 3
pCa pCa
FIGURE 4 Estimation of fluo-3's apparent dissociation constant for Ca2+ (KD). (A) The symbols show the amplitude of fluo-3's fluorescence in solutions
of the indicated pCa (abscissa) minus that measured in a 0 Ca2+ solution: open circles, in the absence of aldolase (viscosity = 1.1 cP); filled circles, in
the presence of 55 mg/ml aldolase (viscosity = 1.6 cP; no added sucrose). For each data set, the fluorescence changes were normalized by that measured
in sat. Ca21 (pCa -2). The curves represent least-squares fits of the data by the prediction of 1:1 binding (cf. Equation 1); the best-fit KD values were 0.51
and 1.09 ,uM (without and with aldolase, respectively). (B) Least-squares fit of the filled circle data from partA with the functional form predicted by Scheme
1 in the text. The best fit values of K2 and KD2 were 366 and 1.92 ,uM, respectively, obtained under the assumption that K2 X KD2 = 703 tLM2 (see text).
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difference spectrum is shown as the dashed curve in panel F.
These spectra calculated for aldolase-bound Fluo-3 are re-
ferred to below as the indicator's spectra in "saturating al-
dolase." It is of interest to note that the Ca2+ difference spec-
trum in saturating aldolase also has a triphasic shape;
however, the isosbestic wavelengths (515 and 549 nm) are
red-shifted by 11-13 nm in comparison with the isosbestic
wavelengths of the 0 aldolase spectrum (504 and 536 nm; cf.
Fig. 2 F).
Part II: In vivo measurements
Fluo-3 signals from resting fibers
Apparent diffusion coefficient. If Fluo-3 in myoplasm i's
not bound to muscle constituents of large molecular weight,
the diffusion of the indicator along the fiber axis should be
described by an apparent diffusion coefficient (Dapp) pre-
dictable from the molecular weight of the compound. For
Fluo-3 (molecular weight of 765 for the penta-valent anion),
Dapp is predicted to be -0.9 X 10-6 cm2 s-' (16, 19, 20). If,
however, Fluo-3 is bound to large and relatively immobile
myoplasmic constituents such as soluble or structural pro-
teins, Dapp will be reduced, and the magnitude of the reduc-
tion can be used to estimate the fraction of the indicator
bound to the immobile myoplasmic constituents (15, 19, 21).
The value of Fluo-3's Dapp was estimated from the am-
plitude of the indicator's absorbance and/or Fluorescence
signals measured at different axial distances from the site of
indicator injection about 1 h after the injection (cf. Refs. 15
and 22). The absorbance measurements were made from rest-
ing fibers, whereas the Fluorescence measurements were
made from either resting fibers or fibers stimulated by an
action potential. The amplitude of the optical signal, which
was assumed to be proportional to the concentration of in-
dicator present at the measurement site, was least-squares
fitted with the solution to the one-dimensional diffusion
equation (cf. Refs. 15, 21, and 22). From the fit, two pa-
rameters were estimated: Dapp and a second parameter M,
proportional to the total quantity of fluo-3 in the fiber. The
values of Dapp so estimated in eight fibers ranged between
0.12 and 0.30 X 10-6 cm2 s-', with the average value ofDapp
being 0.20 (± 0.02) X 10-6 cm2 s-1. (Note: of the eight
experiments, four fibers had resting absorbance measure-
ments only, one fiber had resting fluorescence measurements
only, and three fibers had measurements of more than one
type. For each experiment, a single estimate of Dapp was
obtained based on the average of all estimates available for
that fiber. Of these eight fibers, three were injected with dye
from lot 8E, one was injected with lot lOB-1 and four were
injected with lot 1OD-1. The estimates of Dapp with lots 8E
and lOB-1 represent the only in vivo measurements of this
article made with a lot other than lot 1OD-1.)
Since the average value of Dapp is only -0.22 times that
expected in the absence of indicator binding, -22% of the
indicator molecules in myoplasm appear to be freely diffus-
ible and -78% appear to be bound to immobile myoplasmic
constituents. This percentage of bound indicator is similar to
that estimated for other indicators of the tetracarboxylate
family: 60-85% for fura-2 (9, 20), 80-85% for fura red (1),
and -90% for azo-1 (15).
Absorbance. Fig. 5 shows an example of resting absor-
bance measurements from a fiber injected with fluo-3 and
illustrates the procedures used to estimate the indicator-
related absorbance and the indicator concentration ([DT])D
Similar measurements were carried out in a total of 15 fibers.
Fig. 5 A shows the raw absorbance measurements at seven
wavelengths between 480 and 630 nm. These measurements
were made with two forms of linearly polarized light (circles,
00 polarization; X values, 900 polarization). At A 2 600 nm,
the measurements reflect the intrinsic absorbance of the fiber,
whereas at A < 600 nm, the measurements reflect both the
intrinsic absorbance and the indicator-related absorbance. At
each A < 600 nm, the contribution of the intrinsic absorbance
was estimated from the measurements at A 2 600 nm (see
legend of Fig. 5) and subtracted from the total absorbance to
obtain the indicator-related absorbance (denoted AO(A) and
A90(A) and plotted in Fig. 5 B as circles andXs, respectively).
If fluo-3 is not significantly bound to oriented structures
in the fiber (for example, the myofilaments or the sarco-
plasmic reticulum), the AO(A) and Ago(A) measurements of
Fig. 5 B should, within the error of the measurements, be
equal at all A. Conversely, if some of the indicator molecules
are bound to oriented structures, the polarized absorbances
may differ at one or more A. For the fiber of Fig. 5 B, the Ao
data are slightly greater than the Ago data at four of the five
wavelengths. For the 15 experiments, the mean value of the
dichroic absorbance (defined as AO(A) - Ago(A)) was signif-
icantly greater than zero at A = 500, 510, and 520 nm, i.e.,
at the three wavelengths where the isotropic absorbance (de-
fined as [Ao(A) + 2AgO(A)]/3) was relatively large. At the
other two wavelengths (A = 480 and 540 nm), the dichroic
absorbance was not significantly different from zero. If av-
eraged over all five wavelengths, the mean value of the dich-
roic absorbance divided by the isotropic absorbance was
0.072 (± 0.032 SE;N = 15), a value that is also significantly
different from zero. Thus, the polarized absorbance meas-
urements suggest that a minimum of 0.072/3 = 0.024 of the
fluo-3 molecules are bound to oriented structures in the fiber
(cf. Ref. 23). This evidence for the binding of fluo-3 to ori-
ented structures (see also Ref. 6) contrasts with the results of
similar measurements carried out with fura red, where sig-
nificant binding of fura red to oriented structures was not
detected (1).
In Fig. 5 C, the filled circles show the isotropic absorbance
(denoted A(A)). The dashed curve in Fig. 5 C is fluo-3's
absorbance spectrum measured in a 0 Ca2 , 0 aldolase so-
lution, scaled so as to give a least-squares fit to the fiber data.
The data are not well fitted by this curve. In contrast, a good
fit to the data is obtained if this same spectrum is red-shifted
by 7 nm prior to the fit (continuous curve in Fig. 5 C). Panel
D illustrates analogous fits of the same data with the 0 Ca21
spectrum calculated for the saturating aldolase condition
(dashed curve in Fig. 2 B). This spectral shape gives a rea-
sonable fit to the data, both without a wavelength shift
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FIGURE 5 (A) Absorbance (intrinsic plus indicator-related) of a muscle fiber injected with -0.12 mM fluo-3. Absorbance was measured at seven
wavelengths (abscissa) with two forms of linearly polarized light, one oriented parallel (denoted 00), and the other perpendicular (denoted 900) to the fiber
axis (circles and Xs, respectively). (B) Fluo-3-related absorbance (circles and Xs; absorbances denoted AO, and Ago, respectively), obtained from the data
in A by subtraction of the intrinsic absorbance; note the change in scale on the axes. At each wavelength A the intrinsic absorbance was estimated from
a scaling of A(615) (= the average of the absorbances measured at 600 and 630 nm) by the factor (A/615)1, where Y = 1.1 for the Ao data, and Y = 1.3
for the Ago data (cf. Ref. 15). The data were also corrected, by interpolation, for a small decrease in indicator concentration during the run that resulted
from the diffusion of indicator away from the measurement site. (C and D) The filled circles show the isotropic absorbance of fluo-3 (denotedA(A)), obtained
from the data points in B by the equation: A(A) = [Ao(X)+ 2A9O(A)]/3. The curves in both panels represent best fits to the data with fluo-3's absorbance
spectrum obtained in a 0 Ca2' solution: panel C, 0 aldolase condition (dashed curve, without a wavelength shift; continuous curve with a +7-nm wavelength
shift); panel D, saturating aldolase condition (dashed curve, without a wavelength shift; continuous curve with a -4-nm wavelength shift). The myoplasmic
concentration of fluo-3 ([DT]) estimated from the continuous curves were 122 ,uM in C and 127 J,M in D. For calculation of [DT], the following isosbestic
wavelengths and corresponding molar extinction coefficients were used: for C, 511 nm and 7.83 X 104 M-1 cm-1; for D, 511 nm and 6.99 X 104 M-1 cm-l.
These isosbestic wavelengths represent shifts of +7 nm, and -4 nm, respectively, relative to those given in Methods for the corresponding solutions. Fiber,
062791.1; diameter, 107 ,um; measurement site, 150 ,tm from the injection site.
(dashed curve in Fig. 5 D) and with a 4-nm blue-shift (con-
tinuous curve in Fig. 5 D). (Note: the wavelength shifts used
for the fits of the continuous curves in Fig. 5 were obtained
from the best fits of the fiber AA(A) data with the in vitro
Ca2' difference spectra, as described below in connection
with Fig. 7. Such wavelength shifts of indicator absorbance
spectra in myoplasm are generally more reliable when eval-
uated from AA(A) data than from A(A) data, since, as men-
tioned in Methods, AA(A) data are substantially better re-
solved in our apparatus than are A(A) data.)
Estimation of [DT]. The myoplasmic concentration of
fluo-3 ([DT]) was estimated from fits of wavelength-shifted
curves of the type shown in Fig. 5 (continuous curves). From
the fitted value ofA(A) at the presumed isosbestic wavelength
for Ca2 , [DT] was calculated by Beer's law with the values
of extinction coefficients given in Methods (see legend of
Fig. 5). For the fiber of Fig. 5, the estimates of [DT] were 122
,uM for the fit in panel C and 127 ,uM for the fit in panel D.
For each of the other 14 fibers of Table 2, the two methods
for estimation of [DT] also gave very similar estimates; on
average, [DT] estimated by the method of Fig. 5D was 1.050
(± 0.004;N = 15) times that estimated by the method of Fig.
5 C.
A third estimate of [DT] can be made under the assumption
that the myoplasmic A(A) signal arises as a linear combina-
tion of the indicator's protein-free and protein-bound spectra.
For example, since the Dapp measurements suggest that -0.8
of fluo-3 in myoplasm is bound to immobile myoplasmic
constituents, A(A) might reasonably be approximated as 0.2
times the 0 aldolase spectrum plus 0.8 times the saturating
aldolase spectrum. In general, the fiber A(A) data were well-
fitted with such a composite spectrum, without any wave-
length shift. For the fiber of Fig. 5, the value of [DT] esti-
mated by this method was 125 ,M (fit not shown), a value
very similar to that obtained with the two methods illustrated
in Fig. 5.
Since the estimates of [DT] obtained with the three meth-
ods were nearly identical, estimates based on one method
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TABLE 2 Estimation of Af and fr from lot lOD-1 of fluo-3
fr, if Fmax/Fmin =
Fiber [DT] A[CaD] Af AFIF 100 200
,uM JIM
A. 1.8 mM CaC12
100191.2 141 80 0.57 5.4 0.096 0.101
100391.1 159 63 0.40 4.3 0.083 0.088
101791.1 164 93 0.57 5.9 0.087 0.092
101891.1 77 41 0.53 4.6 0.105 0.110
102291.1 107 63 0.59 4.4 0.124 0.129
102291.2 120 88 0.73 7.6 0.086 0.091
100792.1 40 24 0.60 6.5 0.082 0.087
Mean 0.57 5.5 0.095 0.100
+ SE (n = 7) ±0.04 ±0.5 ±0.006 ±0.006
B. 11.8 mM CaCl2
013191.4 63 50 0.79 8.8 0.080 0.085
020691.1 129 88 0.68 8.0 0.075 0.080
020691.2 40 31 0.78 9.5 0.072 0.077
032691.4 31 13 0.42 5.7 0.064 0.069
062691.3 73 53 0.73 6.2 0.108 0.113
062791.1 122 74 0.61 6.4 0.085 0.090
082291.1 67 51 0.76 9.6 0.069 0.074
082291.2 89 64 0.72 8.8 0.072 0.077
Mean 0.69 7.9 0.078 0.083
± SEM (n = 8) ±0.04 ±0.6 ±0.005 ±0.005
C. Parts A and B combined
Mean 0.63 6.8 0.086 0.091
+ SE (n = 15) ±0.03 ±0.5 ±0.004 ±0.004
Absorbance and fluorescence measurements were made from a localized region of a single fiber injected with fluo-3 (lot 1OD-1). In part A, the fibers were
in normal Ringer ([Ca2l] = 1.8 mM); in part B, the fibers were in high Ca2+ Ringer ([Ca2+] = 11.8 mM). Column 1 gives the fiber identification number
and col. 2 gives the total concentration of indicator. Columns 3-5 give the peak changes in concentration of Ca2e-indicator complex, the fraction of fluo-3
complexed with Ca2+, and fluo-3's fluorescence intensity resulting from action potential stimulation. fr (columns 6 and 7) was estimated from Eq. 4 for
two assumed values of Fmj,,,iF,: 100 (column 6) and 200 (column 7). The means and standard error of the means (± SE) are listed below columns 4-7.
Part C gives the means (± SE) for all fibers from parts A and B.
only, that illustrated in Fig. 5 C (continuous curve), are re-
ported for the 15 fibers (column 2 of Table 2). For all ex-
periments, [DT] was sufficiently small, <200 ,AM, that
[Ca21]r should not have been reduced significantly below its
normal value due to the fact that indicator was injected from
a solution that contained no added Ca21 (cf. Ref. 1).
Fluo-3 signals in response to action potential stimulation
Absorbance changes. Fig. 6A shows examples, at sev-
eral incident wavelengths, of the fractional change in trans-
mitted light intensity (Al/I) of a fiber injected with fluo-3 and
stimulated by a single action potential initiated at zero time.
At each wavelength, two traces are shown, those measured
with 00 (arrowed traces) and 900 polarized light. Fig. 6 B
shows the 1:2 weighted average of the 00 and 900 signals at
each incident wavelength after correction for the intrinsic
transmission change and calibration in absorbance units (see
legend of Fig. 6).
Estimation of A[CaD]. In Fig. 6 B, the wavelength de-
pendence of AA is qualitatively that expected for an increase
in the concentration of Ca2+-fluo-3 complex (A[CaD]). An
estimate of the amplitude of A[CaD] is facilitated by a com-
parison of the wavelength dependence of AA(A) with that of
an in vitro Ca2' difference spectrum. This comparision is
shown in Fig. 7. In each panel the ordinate gives the am-
plitude of the fiber AA signal (filled circles) at a particular
A relative to that at A = 520 nm. At the five A values other
than 520 nm, relative signal amplitude was estimated from
the scaling constant that provided a least-squares fit of the
rising phase of the AA(520) waveform to that of the AA(A)
waveform. For the fiber of Fig. 6, and for most fibers listed
in Table 2, the waveforms recorded at the different A were
very similar up until the time of their peak; after the peak,
the waveforms usually differed slightly, possibly due to con-
tamination of the traces by a movement artifact or possibly
due to an unidentified component of the fluo-3 response.
Thus, in general, AA(A) amplitudes were estimated from fits
of the waveforms through time to peak only.
The fiber data in the three panels of Fig. 7 are identical,
whereas the curves represent best fits of the data with Ca21-
difference spectra estimated for three different in vitro con-
ditions. As in Fig. 5, a dashed curve represents the in vitro
spectrum without a wavelength shift, whereas a continuous
curve incorporates a shift along the wavelength axis. The
shifts were +7 nm for the curve in panel A (0 aldolase con-
dition) and -4 nm for the curve in panelB (saturating aldolase
condition). These shifts represent the average of the shifts,
separately estimated for each of the 15 fibers, that yielded the
best least-squares fit of these spectral shapes to the fiber
AA(A) data: 7.2 (±0.1) and -3.9 (±0.1), respectively.
From (i) the values of the extinction coefficient changes
given in Methods, (ii) the relative amplitude of AA(A)
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FIGURE 6 Absorbance and fluorescence changes measured in response to a single action potential. (A) Changes in transmitted intensity at six wavelengths
(indicated in nanometers to the left). At each wavelength, the changes were measured with 00 (arrowed traces) and 90° polarized light. (B) The indicator-
related isotropic absorbance changes, obtained as the 1:2 weighted average of the 00 and 900 traces from A after subtraction of the estimated change in fiber
intrinsic absorbance. At each A, the intrinsic change was assumed to be given by AA630 scaled by the factor (A/630)1 6. The calibration in B is in AA units
(= -(1/lnlO)AJ/I). (C) The fractional change in fluo-3 fluorescence, recorded immediately before, and immediately after the records in part A; the larger
trace was recorded first. (D) The average of the fluorescence traces from C (continuous trace) compared with the AA520 trace from B (dotted trace) scaled
so that its peak value was the same as that of the fluorescence trace. Same experiment as Fig. 5.
calculated from the continuous curves in Fig. 7, and (iii) the
absolute amplitude of AA(520) in Fig. 6 B, A[CaD] was es-
timated by Beer's law (see legend of Fig. 7). The value es-
timated from the fit of Fig. 7A was 74 ,M and from the fit
of Fig. 7 B was 96 ,tM. Similar relative differences in
A[CaD] were estimated with the two fitting procedures ap-
plied to the other fibers of Table 2. On average (N = 15),
A[CaD] estimated by the method of Fig. 7B (data not shown)
was 1.26 (± 0.01) times that estimated by the method of Fig.
7 A (column 3 of Table 2). Fits based on the method of Fig.
7 B had substantially larger sum-of-squares deviations, on
average, 6.30 (± 0.49) times larger, than those based on the
method of Fig. 7 A. This indicates that the overall shape of
the curve used in the method of Fig. 7A is substantially closer
to that of the muscle data than is the shape of the curve used
in Fig. 7 B. If the extinction coefficients applicable to the
curve in Fig. 7A are also closer to those that apply to fluo-3
in the myoplasmic environment, then estimates of A[CaD]
based on the method of Fig. 7 A will be more accurate than
those based on the method of Fig. 7 B.
The curve in Fig. 7 C represents a composite Ca2+ dif-
ference spectrum calculated from Scheme 1 and the four
absolute spectra shown in panels B and D of Fig. 2. The
construction of this spectrum started from the assumption
that, in the absence of Ca2 , 0.2 of the fluo-3 molecules are
protein-free and 0.8 are protein-bound, the approximate dis-
tribution inferred from the measurements of Dapp (see
above). The shape of the composite 0 Ca2+ spectrum was
thus obtained as 0.2 times the 0 aldolase spectrum of Fig. 2
B plus 0.8 times the saturating aldolase spectrum of Fig. 2
B. Similarly, the composite sat. Ca2+ spectrum was based on
a 0.48:0.52 weighting of the two sat. Ca2+ spectra shown in
Fig. 2 D. The weighting for this combination was that cal-
culated from Scheme 1 for the fraction of fluo-3 in the CaD
and CaPD forms at sat. Ca21 (0.48 and 0.52, respectively, if
[DT] = 122 ,kM and [aldolase] = 84 mg/ml; this value of
[DT] agrees with the estimate from Fig. 5 A, and the two
concentrations together predict a 0.2:0.8 distribution for D
and PD at 0 Ca2+). The shape of the composite Ca2' dif-
ference (curve in Fig. 7 C) was then obtained as the differ-
ence between the composite spectra calculated for sat. and
0 Ca2 . Since it is clear that a scaled version of this difference
spectrum would not fit the data well with any wavelength
shift, no attempt was made to estimate A[CaD] from this fit.
(Note: if a composite Ca2+ difference spectrum is calculated
under the assumption of a partial, rather than complete, re-
action of indicator with Ca2+, a spectral shape indistinguish-
able from that shown in Fig. 7 C is obtained.)
The lack of agreement between the fiber data and the spec-
tral curve in Fig. 7 C indicates that one or more assumptions
used to construct the composite curve are inaccurate. In par-
ticular, it does not appear that there exists a single bound pool
of fluo-3 in myoplasm that can be modeled with the fluo-
3:aldolase reaction that was used to fit the in vitro data
(Scheme 1). Thus, in myoplasm, fluo-3 may be substantially
bound to muscle constituents other than aldolase (cf. the de-
tection of indictor binding to oriented structures discussed
above), or, if substantially bound to aldolase, may have prop-
erties different from those modeled by our in vitro buffer
solution.
Estimation of Af, the fractional change in Ca2+-bound
indicator. From the estimates of .[CaD] and [DT], lfwas
calculated (= A[CaD]/[DT]). These estimates are given in
column 4 ofTable 2 for the fits based on the 0 aldolase spectra
(cf. procedures illustrated in Figs. 5 C and 7 A). The average
value of Af observed for seven fibers in normal Ringer (part
Harkins et al. 875
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A ofTable 2) was 0.57 (± 0.04); this value is not significantly
different from the 0.69 (± 0.04) value observed for eight
fibers in high Ca2' Ringer (part B of the Table 2).
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FIGURE 7 Each panel shows the normalized amplitude of the change in
fluo-3's isotropic absorbance (filled circles) estimated from the records in
Fig. 6 B, and compared with a Ca2" difference spectrum measured in vitro
(curves). Normalized signal amplitude was determined at each A from the
scaling constant that gave a best fit of the AA520 waveform to the AA(A)
waveform; the waveforms were fitted through time-to-peak of the AA520
waveforms (-15 ms after stimulation). All signal amplitudes were also
corrected for a small drift during the run, by an interpolation based on the
change in amplitude of the 520-nm signal. In A, the data were least-squares
fitted by a 0 aldolase difference spectrum (dashed curve), and by this spec-
trum red-shifted by 7 nm (continuous curve). In B, the data were fitted by
a saturating aldolase difference spectrum (dashed curve) and by this spec-
trum blue-shifted by 4 nm (continuous curve). The values of A[CaD] es-
timated from the fits were 74 ,g.M (A) and 96 ,uM (B). The extinction
coefficients used in these calculations are given in Methods (where the
wavelengths of the positive and negative peaks in the difference spectrum
are referenced to the unshifted curves). See text for discussion of C. Same
experiment as Figs. 5 and 6.
Af estimated from the saturating aldolase spectra (values
not shown in Table 2; cf. Figs. 5 D and 7 B) was, on average,
1.20 (± 0.01; N = 15) times that estimated from the 0 al-
dolase spectra. As mentioned above, estimates based on the
saturating aldolase spectra may be less accurate than those
based on the 0 aldolase spectra because the sum-of-squares
deviations of the fits were substantially larger with the former
than with the latter.
Fluorescence changes. Examples of the change in
fluo-3 fluorescence intensity (AF) measured in response to
a single action potential are shown in Fig. 6 C. One of these
records (AF/F at peak = 6.9) was taken immediately before,
and the other (AF/F at peak = 5.9) immediately after, the
transmission records shown in Fig. 6 A. The direction of AF
is that expected for a transient increase in the concentration
of Ca2+-bound fluo-3. Panel D of Fig. 6 shows the average
of the two fluorescence records from panel C compared with
a scaled version of the AA(520) trace from panel B. The AA
and AF waveforms are very similar, as expected if they both
reflect A[CaD].
For the 15 fibers, column 5 of Table 2 gives the amplitude
of AF/F determined at the same time as the £4 signals used
to estimate the A[CaD] values given in column 3 of Table 2.
For fibers in normal Ringer, the average peak value of AF/F
was 5.5 (± 0.5); for fibers in high Ca2+ Ringer, the average
peak value was 7.9 (± 0.6). These values are statistically
different; the reason for this difference is not known.
Estimation of f,
According to Equation 4, fr, the resting fraction of fluo-3 in
the calcium-bound form, can be determined from the meas-
urements of Af and AF/F and from an assumed value of
FMAX/FMIN. Table 2 listsfr values estimated for the 15 fibers
under two assumptions: FMAX/FMIN = 100 (column 6) and
FMAX/FMIN = 200 (column 7). The latter value is that ob-
served in a 0.1 M KCI solution at pH = 7.0 (cf. Table 1); the
former value is a reasonable estimate for fluo-3 when in the
aldolase-bound form (cf. Fig. 3 B). Given that a large fraction
of fluo-3 appears to be bound to intracellular constituents of
large molecular weight (see above), we think a value sub-
stantially lower than 200, but probably above 100, likely
applies to fluo-3 in the myoplasmic environment. However,
since both values of FMAX/FMIN are large, the estimates of
fr in columns 6 and 7 ofTable 2 differ by only a small amount,
5-6%. For the fibers in normal Ringer, the average value
of fr is 0.095 (± 0.006) if FMAx/FMIN = 100 and 0.100
(+ 0.006) if FMAX/FMIN = 200. For the fibers in high Ca2+
Ringer, the corresponding values are 0.078 (± 0.005) and
0.083 (± 0.005). At each value ofFMAX/FMIN, the estimates
of fr for the two types of Ringer solution are significantly
different. Again, the reason for this difference is not known.
It is possible, however, that it simply represents statistical
variability since (i) the difference is not large, and (ii) in
analogous measurements with fura red, a difference in fr of
similar magnitude, but of opposite polarity, was found for the
two types of Ringer solution (1).
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Estimation of KD in the myoplasmic environment
Because fluo-3 appears to bind heavily to myoplasmic con-
stituents, it is likely that the effective KD of the indicator in
vivo is different from the 0.51 ,uM value measured in vitro
in a 0.1 M KCI solution (cf. the effect of aldolase in Fig. 4
A). In order to estimate KD in myoplasm, measurements of
the type shown in Fig. 8 were carried out. In this experiment,
the fiber was injected simultaneously with two Ca2" indi-
cators: furaptra (24) and fluo-3. Furaptra is a rapidly reacting
Ca21 indicator that tracks the change in myoplasmic free
[Ca21] in response to an action potential with little or no
kinetic delay (25). In Fig. 8, the furaptra Ca21 transient (dot-
ted traced labeled A[Ca2+]) has a brief time course, with a
time to peak of 6.0 ms and a half-width of 10.2 ms, while the
fluo-3 signal (dotted trace labeled Af) has a much slower
time course, with a time to peak of 15.2 ms and a half-width
of 47.4 ms. The slow time course of the fluo-3 signal is
assumed to reflect delays imposed by the effective on- and
off-rate constants of a single-site reaction of fluo-3 with Ca21
(reaction rates denoted k+ 1 and k-1, respectively). These rates
can be estimated from the experimental traces (see legend of
Fig. 8) by the method previously described for other indi-
cators (1, 9, 26, 27). The ratio k-1/k+1 then gives the estimate
of KD. Similar measurements were made in a total of three
fibers. The average values of k+1, k-1, and KD were 1.31
(± 0.12) x 107 M-1 s-1, 33.5 (± 2.2) s-1, and 2.57 (± 0.07)
,M, respectively. This in vivo estimate of KD is 5.0 times
A[CaJ -;
.- */ao
0 20 40 ms
FIGURE 8 Illustration of the method used to estimate the on- and off-rate
constants, and hence KD, of the Ca2"-fluo-3 reaction in myoplasm. The fiber
was simultaneously injected with furaptra, and fluo-3, and stimulated at zero
time to give an action potential. The trace labeled A[Ca] is the waveform
of the free calcium transient determined from furaptra with 420-nm exci-
tation (25); its calculation here includes correction for a small interference
from fluo-3's fluorescence change at 420 nm, the amplitude of which was
independently estimated in other experiments. The peak amplitude of
A[Ca21] was 15.3 ,uM (after a 2-fold scaling to account for the calibration
error described in Ref. 25). Two traces labeled Af are shown. The dotted,
and slightly noisier, trace is the change in the fraction of fluo-3 in the
Ca2+-bound form, proportional to the measured AF from fluo-3. The peak
amplitude of Af was assumed to be 0.656, the value estimated from the
measured amplitude of AF/F (= 7.3) and a linear regression analysis, ap-
plied to the 15 experiments in Table 2, that related Af and AF/F. The con-
tinuous trace is a least-squares fit of Af under the assumption that Af rep-
resents a single site response driven by A[Ca21]; the best fit values of k+1
and k-, were 1.52 X 107 M-1 s-1 and 37.5 s-1, respectively. The corre-
sponding estimate ofKD (= k1l/k+ 1) is 2.47 ,M. For the fit, fr was assumed
to be 0.082 (Equation 4), and [Ca21]r was assumed to be 0.22 ,M; the latter
value is consistent with anfr of 0.082, and aKD of 2.47 ,uM. Fiber 100992.1;
diameter, 111 gm; measurement site, 75 ,um from the injection site.
larger than the in vitro estimate obtained in the absence of
aldolase and 2.4 times larger than that obtained in the pres-
ence of aldolase (Fig. 4).
Estimation of [Ca2+],
Columns 2-4 of Table 3 list estimates of [Ca21]. calculated
from Equation 1 with three assumed values ofKD: 0.51, 1.09,
and 2.57 ,utM. The value of fr given in column 1 of the Table
is that from part C of Table 2 for FMAX/FMIN = 100. (As
mentioned above, we think an FMAX/FMIN of 100 is more
likely to apply to the protein environment of myoplasm than
an FMAX/FMIN of 200). The values of [Ca21]r in Table 3
denoted by asterisks, 103 and 242 nM, reflect the values of
KD that we think are more likely to apply to myoplasm. (As
mentioned above, because fluo-3 is heavily bound to myo-
plasmic constituents, we think a KD of 0.51 ,uM is unlikely).
AF in response to a train of action potentials
Previous work indicates that when a fiber is stimulated by a
brief, high-frequency train of action potentials (e.g., 5-10
shocks given at 50-100 Hz), A[Ca2+] reaches its largest
value in response to the first shock, and, in response to the
subsequent shocks, the average value of A[Ca2+] reaches a
quasi-steady level that is typically about 0.8 times that of the
initial peak (19, 20, 25). On the other hand, Fig. 8 indicates
that, with a single action potential, A[Ca2+] is only about 0.5
of its initial peak by the time to peak of the fluo-3 signal.
Thus, it is expected that, during a brief high-frequency train,
fluo-3's fluorescence signal would increase slightly, perhaps
- 10%, above the level reached in response to a single shock.
This follows since Table 2 indicates that the peak fraction of
fluo-3 in the Ca2+-bound form in response to a single action
potential is already large, about 0.72 (= 0.086 + 0.63; part
C of Table 2, columns 4 and 6).
Fig. 9 shows results from an experiment designed to test
this point. In response to a single shock, the peak value of
AF/F was 6.71, whereas in response to a five-shock train
given at 67 Hz, the average value of AF/F between the sec-
ond and fifth peaks was 7.24. Thus, the average level of
fluorescence achieved during the train was about 1.08 times
that of the peak value resulting from a single action potential.
TABLE 3 Summary of estimates of fr and [Ca2+]r from fluo-3
Resting [Ca2+]. (nM) for the specified value of KD (tKM):
fr KD= 0.51 KD = 1.09 KD= 2.57
0.086 48 103* 242*
From fr (column 1), the estimates of [Ca2,]r were calculated with Eq. 1 for
three assumed values of KD. The value of fr is that given in part C of Table
2 (column 6). The values ofKD, columns 2-4, were estimated, respectively,
from in vitro measurements in the absence of aldolase (Fig. 4A, open cir-
cles), in vitro measurements in the presence of aldolase (Fig. 4A, filled
circles), or from in vivo kinetic fits of the type shown in Fig. 8.
* Estimates calculated from the values of KD that we think may apply to
fluo-3 in the myoplasmic environment.
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FIGURE 9 Fluo-3 fluorescence changes in response to one and five action
potentials. At 0 time, the fiber was stimulated by either one shock (briefer
response) or by a train of five shocks separated by 15 ms. The value of F
(in arbitrary units proportional to light intensity) was 75.7 for the single-
shock response and 74.7 for the five-shock response. Fiber, 020691.1; di-
ameter, 62 ,um; the measurement site was located at the injection site.
Similar results were found in a total of four fibers stim-
ulated by a brief, high-frequency train (5-10 shocks given at
67-77 Hz). The average value of AF/F resulting from the
second through fifth shocks was 1.12 (± 0.07) times that of
the peak ofAF/F resulting from the first shock. Overall, these
results are very close to expectation and imply that, during
a brief high-frequency tetanus, -0.8 of the total fluo-3 mole-
cules become complexed with Ca2+.
Effects of elevated [K+] in Ringer
In experiments with aequorin, it was concluded that a Ca21_
dependent luminescence signal could not be reliably detected
in resting fibers in normal Ringer solution (22). If, however,
the potassium concentration in Ringer ([K+]) was increased
from 2.5 to 12.5 mM, an increase in aequorin's luminescence
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was readily detected (3), which was presumed to reflect an
increase in [Ca2"]r. The goal of the experiments described
in this section was to obtain analogous information regarding
the sensitivity of fluo-3's resting fluorescence signal to
changes in Ringer potassium concentration.
In the experiments with fluo-3 described in the preceding
sections, the fluorescence level from a fiber at rest is pre-
dicted to be 9.5 times that ofFMIN (ifFMAx/FMIN is 100 and
fr is 0.086; cf. Table 3 and Equation 2). For an average sized
fiber containing -0.1 mM fluo-3, resting F is typically four
to five times the amplitude of the cross-talk intensity of our
apparatus (see Methods). Thus, restingF is well-resolved and
a well-resolved increase in F would be expected with in-
creases in Ringer [K+] that produce substantial increases in
[Ca2+]r.
In Fig. 10 A, the abscissa shows time after injection of
fluo-3 into a fiber and the ordinate shows the value of F
recorded when the fiber was exposed to different [K+] levels
between 2.5 and 12.5 mM. F levels recorded at 2.5 mM [K+]
are shown as filled circles and at elevated [K+] as open cir-
cles. The steady decrease in the filled circle data with time
is presumed to reflect a decrease in fluo-3 concentration due
to the diffusion of indicator away from the measurement site.
To characterize this decrease empirically, the filled circle
data were fitted with a declining 2-exponential function. This
fitted curve (dashed line) then permitted normalization of the
F values recorded at elevated [K+] by the values of F that
would have been measured at similar times if the fiber had
been left in 2.5 mM [K+].
In the experiment of Fig. 10A, increases in F were readily
detected at all [K+] levels between 5 and 12.5 mM. These
increases are presumed to reflect increases in [Ca2]]rand
indicate that fluo-3's F signal is a sensitive monitor of these
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FIGURE 10 The effect of an elevation in Ringer [K+] on the fluorescence signal from fluo-3 in a nonstimulated fiber. (A) The ordinate plots resting
fluorescence (in arbitrary units) measured at different times after the injection of fluo-3 (abscissa). The fiber was in high Ca2' Ringer at the time of the
injection and then returned to normal Ca2' Ringer for the duration of the experiment. The measurements in normal Ringer (2.5 mM [K+]) are shown as
solid circles and the measurements in elevated [K+] Ringer are shown as open circles. The periods in elevated [K+] and the values of [K+], are indicated
at the top of the panel. The dashed curve is a best fit of the filled circle data with a declining 2-exponential function (F = F1 X exp(-t/Tr) + F2 X exp(-t/T2)).
Fiber 100191.2; diameter, 63 gm; measurement site, 50 ,um from the injection site. (B) Normalized fluorescence values (see text) calculated from the
experiment of part A (circles) and from two other experiments (triangles, fiber 100391.2; squares, fiber 100391.1) plotted as a function of Ringer [K+].
By definition, the normalized F value at 2.5 mM [K+] was 1.0 for all fibers (denoted X in the plot).
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increases. Similar results were found in two other fibers. In
one of these fibers (100391.2), F levels at [K+] 2 10 mM
clearly decayed more rapidly than F levels in 2.5 mM [K+]
(i.e., as seen in the fiber of Fig. 10 A). The reason for these
decays in F is not known but is presumed to reflect a decline
in the elevated [Ca21]r level produced by the elevated [K+].
For each of the fibers studied in elevated [K+] Ringer, an
average "normalized F value" was calculated from all avail-
able measurements at each of the elevated [K+] levels (three
to six data points/fiber/elevated [K+] level, which were
measured over periods of 3-14 min and normalized to the
predicted F values in 2.5 mM [K+]). For the three fibers, the
normalized F values (Fig. 10 B) varied from 1.5 to 2.7 at
[K+] = 5 mM, 2.1 to 3.5 at [K+] = 7.5 mM, 2.4 to 4.9 at
[K+] = 10 mM, and 2.5 to 5.4 at [K+] = 12.5 mM. Under
the assumption that FMAX/FMIN = 100 and fr = 0.086, the
means of the normalized F levels recorded in 5, 7.5, 10, and
12.5 mM [K+] correspond tOfr levels of 0.172, 0.249, 0.326,
and 0.345, respectively. The corresponding levels of [Ca2+].
are, respectively, 2.2, 3.5, 5.1, and 5.6 times the value of
[Ca2+]r in 2.5 mM [K+] (independent of the choice of KD).
DISCUSSION
A novel method for estimation of [Ca2+Jr with
fluo-3
This article describes absorbance and fluorescence measure-
ments with fluo-3, both from in vitro calibration solutions
and from single muscle fibers injected with the indicator. An
unexpected finding of the in vitro measurements was that
FMAX/FMIN was -200 (at least for the principal lot of the
indicator used for the measurements of this article), a value
nearly 5-fold larger than previously reported (4). The large
value ofFMAX/FMIN provides the basis for a novel calibration
procedure for estimation of fr (the fraction of fluo-3 in the
Ca2+-bound form in a resting fiber). The procedure has the
advantage that it does not employ invasive or irreversible
techniques to estimate FMAX and FMIN in the myoplasm, but
it has the disadvantage that it is technically somewhat cum-
bersome. According to Equation 4 in Methods, fr can be cal-
culated from three quantities: (i) Af, the change in the fraction
of Ca2+-bound fluo-3 in response to electrical stimulation;
(ii) AF/F, the fractional change in fluorescence in response
to electrical stimulation; and (iii) a correction term equal to
(1 - FMAx/FMIN)1. Although the exact value ofFMAX/FMIN
in myoplasm is not known, the correction term is likely to
be small since FMAX/FMIN exceeded 100 in the various in
vitro calibrations, including those carried out in the presence
of a large concentration of aldolase (122 mg/ml).
With the average concentration of fluo-3 used in the ex-
periments, -0.1 mM, the measurements of F and AF are
well-resolved in our apparatus. Thus, the principal uncer-
tainty in the estimation offr arises in the estimation of Af. Af
is calculated as the ratio of two quantities, A[CaD] (the
change in concentration of Ca21 :fluo-3 complex in response
to an action potential) and [DT] (the total indicator concen-
tration). Estimation of these concentrations depends on meas-
urements of fluo-3's absorbance, both at rest (A) and during
activity (AA). In frog single muscle fibers, the resolution of
both of these signals by our apparatus is sufficient to permit
estimation of [DT] (from A) and A[CaD] (from AA). (It
should be noted, however, that technical difficulties are ex-
pected in the measurement of A and AA in cells of smaller
diameter and/or with smaller-sized Ca2+ transients.)
The estimation of Af also depends on the values assumed
for the indicator's molar extinction coefficients (E) in the
myoplasmic environment. Several findings indicate that the
values of E in myoplasm are not identical to the values meas-
ured in a 0.1 M KCI buffer solution: (i) fluo-3's myoplasmic
spectra (A(A) and AA(A)) were not well fitted by the in vitro
spectra unless these spectra were red-shifted by -7 nm (if
solution viscosity = 2 cP); (ii) -0.8 of the fluo-3 molecules
in myoplasm appear to be bound to myoplasmic constituents
such as soluble and structural proteins; and (iii) in vitro, E was
altered somewhat by the addition of aldolase to the calibra-
tion solution. Interestingly, in vitro spectra measured in the
presence of aldolase are characterized by a red-shift as well
as a reduction in amplitude of E. Somewhat surprisingly,
however, the fiber A(A) and AA(A) data were less well fitted
with fluo-3's aldolase-bound spectra than with a red-shifted
0 aldolase spectra. The very good fits obtained with these
latter spectra suggest that the estimates of Alf in Table 2 (cal-
culated from the shifted 0 aldolase spectra) are reasonably
accurate. If the Af estimates had been calculated from the
aldolase-bound spectra, they would have been larger by
-20%; this, in turn, would have increased the estimates of
fr by -20% and of [Ca2+] by -22%.
The remaining variable that affects the calculation of
[Ca2+]. is the choice of the indicator's KD for Ca2+. Two
lines of evidence suggest that fluo-3's KD in myoplasm is
likely to be larger than the 0.5 ,uM value measured in a 0.1
M KCI solution (pH 7, 16°C). Firstly, KD measured in the
presence of 55 mg/ml aldolase was -1.1 ,uM (Fig. 4). Sec-
ond, a kinetic analysis of simultaneous measurements of AF
signals from fluo-3 and furaptra in response to an action
potential (cf. Fig. 9) indicated that KD may be as large as 2.6
,uM. Two possible sources of error exist in the method used
to obtain the in vivo estimate ofKD: (i) the method by which
the furaptra Ca2+ transient is calibrated, which ultimately
relies on calibration of the A[Ca2+] signal measured with
purpurate indicators (purpurate diacetic acid and tetrameth-
ylmurexide (TMX); see discussion in Ref. 25), and (ii) the
assumption of a spatially uniform pool of Ca2+ and indicator
in myoplasm. Since A[Ca2+] in response to a single action
potential is likely to have substantial spatial nonuniformity
(28), the estimate ofKD from the in vivo measurements could
involve some inaccuracy. The estimates of [Ca21]r in Table
3 denoted with asterisks, 103 and 242 nM, reflect choices of
KD that we think are reasonable estimates for myoplasm. As
discussed in Ref. 1, estimates of [Ca2+] made from highly
stretched fibers (sarcomere length, -3.8 ,tm) may exceed
slightly (by 5-10%) estimates made from fibers at shorter
sarcomere length (-2.7 ,um).
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The smaller of the asterisked [Ca2+]r estimates in Table 3
is near the upper end of the range of values (0.02-0.12 AM)
previously estimated with aequorin and Ca2+-selective mi-
croelectrodes (cf. Introduction), whereas the larger of the
estimates is in good agreement with the estimates obtained
with fura red, 0.18-0.27 ,uM (1). We find it particularly in-
teresting that [Ca21]. estimates based on the in vivo estimates
of KD (1.05 ,uM for fura red, 2.57 ,M for fluo-3) are es-
sentially identical with the two indicators: 0.22 p,M with fura
red, 0.24 ,uM with fluo-3 (Ref. 1 and Table 3). This finding
suggests to us that [Ca21]. may indeed be close to this level
since (i) the methods for estimation of fr are very different
with the two indicators, and (ii) the in vivo estimates of KD
are likely to more accurately reflect indicator properties in
myoplasm than the in vitro estimates obtained in the presence
of aldolase. Although we cannot absolutely exclude the pos-
sibility that [Ca21]r in our fibers is elevated due to some
experimental variable, previous results with fura red suggest
that elevations due to factors such as injection damage and
long sarcomere length are likely to be minor (1).
Relationship of [Ca2 ] estimates to contractile
activation
The significance of a [Ca2+]r level of 0.2-0.3 ,uM to the
resting state of a skeletal muscle fiber was discussed previ-
ously (1). The experiments in this article supply new infor-
mation about the level of myoplasmic [Ca2+] at the threshold
for activation of the myofilaments (denoted [Ca2+]t). Ac-
cording to earlier work with elevated [K+] levels in Ringer
(e.g. 3, 22, 29), fiber tension and/or movement becomes sig-
nificant when [K+] reaches 15-20 mM. Our results with
elevated Ringer [K+] (cf. Fig. 10 and last paragraph of Re-
sults) suggest that the fraction of fluo-3 in the Ca2' bound
form at threshold (denoted ft) is probably -0.4 (i.e., some-
what greater than the 0.35 average value observed at 12.5
mM [K+]). Thus, according to Equation 1, [Ca2+], is pre-
dicted to be 0.67 times the KD of fluo-3 for Ca2 , or -1.7
,uM if KD is 2.57 ,tM. This value of [Ca21]t is generally
consistent with tension-pCa curves from skinned fibers,
where, at a temperature of -16°C, a pCa of 6.2 to 6.0 (or
equivalently, a [Ca2+] of 0.6 to 1.0 ,uM) is required to ac-
tivate tension to a few % ofmaximum, both in fibers ofRana
pipiens (30) and Rana temporaria (M. A. P. Brotto and R. E.
Godt, personal communication).
Our results with fluo-3, in combination with earlier find-
ings, also supply information about the steepness of the
tension-pCa relationship in intact fibers. Previous experi-
ments (e.g. Refs. 22, 29, and 30) indicate that the level of
tension achieved in response to a brief, high-frequency train
of action potentials corresponds to nearly full activation of
the myofilaments. As mentioned in Results, during brief,
high-frequency stimulation, the fraction of fluo-3 complexed
with Ca2+ probably rises to -0.8, on average. Thus, nearly
full activation of the myofilaments is predicted to occur when
[Ca2+] is -4 times the KD of fluo-3 for Ca2+ (or -10 ,uM
if KD is 2.57 ,uM). Independent of the choice of KD, the
measurements imply that the myofilaments go from thresh-
old activation to nearly full activation as [Ca2"] increases by
a factor of -6 (from -?-0.67 times fluo-3's KD to -4.0 times
KD), or, equivalently, with a change in pCa of -0.78. This
predicted steepness of the tension-pCa relationship for intact
fibers is consistent with that observed for skinned fibers,
where a pCa change of 0.5-0.9 is typically required to in-
crease myofilament activation from -5 to -95% of maxi-
mum (e.g., Refs. 30-32).
The need for a better calibration solution to
mimic the myoplasmic environment
At least 11 Ca21 indicator molecules have been used to date
to estimate [Ca2+]. or A[Ca21] in frog muscle fibers (for
references, see Ref. 1). With every indicator, evidence has
been found that a substantial fraction of the indicator mole-
cules is bound to intracellular constituents. Moreover, with
most indicators, this binding appears to alter one or more
indicator properties relevant to an accurate calibration of
[Ca2+] (e.g., extinction coefficients, fluorescence excitation
spectra, apparent KD). Thus, it seems highly desirable to
calibrate indicator properties in solutions that mimic the my-
oplasmic environment more closely than does a 0.1 M KCl
solution. We have utilized a 0.1 M KCI solution with variable
concentrations of added aldolase for this purpose (Refs. 1 and
9 and this paper). While the aldolase solutions provide useful
suggestions about the way in which indicator properties
might be altered by the intracellular environment, substantial
uncertainty exists concerning the actual alteration.
The results of this article and of ref. 1 highlight several
inadequacies of the aldolase-KCl calibration solution. For
example, with fura red, the indicator's myoplasmic absor-
bance spectra (A(A) and AA(A)) were better fitted by in vitro
spectra measured in the absence of aldolase than in the pres-
ence of aldolase, even though -85% of fura red appeared to
be bound to muscle constituents of large molecular weight.
With fluo-3, in contrast,A(A) data from myoplasm were gen-
erally better fitted with in vitro spectra measured in the pres-
ence rather than the absence of aldolase (cf. dashed curve in
Fig. 5 D vs. dashed curve in Fig. 5 C). On the other hand,
fits of fluo-3's AA(A) data were clearly less good if based on
Ca2' difference spectra measured in the presence of aldolase
(cf. curves in panels B and C of Fig. 7) than if based on a
red-shifted version of the Ca2' difference spectrum meas-
ured in the absence of aldolase (continuous curve in Fig. 7
A). Thus, with both indicators, the procedures adopted to
estimate [DT] and A[CaD] involved one or more empirical
assumptions. Clearly, additional studies, both in vivo and in
vitro, are required to fully characterize the behavior of in-
dicator molecules in the myoplasmic environment.
We thank Dr. S. Hollingworth for comments on the manuscript and Dr.
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matographic analysis of fluo-3's purity.
880 Biophysical Journal
Harkins et al. Fluo-3 Signals from Muscle Fibers 881
REFERENCES
1. Kurebayshi, N., A. B. Harkins, and S. M. Baylor. 1993. Use of fura red
as an intracellular calcium indicator in frog skeletal muscle fibers. Bio-
phys. J. 64:1934-1960.
2. DeMarinis, R. M., H. E. Katerinopoulos, and K. A. Muirhead. 1990.
New tetracarboxylate compounds as fluorescent intracellular calcium
indicators. Biochem. Meth. 112:381.
3. Blatter, L. A., and J. R. Blinks. 1991. Simultaneous measurement of
Ca21 in muscle with Ca electrodes and aequorin. Diffusible cytoplasmic
constituent reduces Ca2+-independent luminescence of aequorin. J.
Gen. Physiol. 98:1141-1160.
4. Minta, A., J. P. Y Kao, and R. Y. Tsien. 1989. Fluorescent indicators
for cytosolic calcium based on rhodamine and fluorescein chro-
mophores. J. Bio. Chem. 264:8171-8178.
5. Grynkiewicz, G., M. Poenie, and R. Y. Tsien. 1985. A new generation
of Ca21 indicators with greatly improved fluorescence properties. J.
Biol. Chem. 260:3440-3450.
6. Hollingworth, S., A. B. Harkins, and S. M. Baylor. 1990. Absorbance
and fluorescence signals from fluo-3 in isolated frog skeletal muscle
fibres. J. Physiol. 430:68P.
7. Harkins, A. B., N. Kurebayashi, S. Hollingworth, and S. M. Baylor.
1991. Absorbance and fluorescence signals from fluo-3 in intact twitch
fibers from frog muscle. Biophys. J. 59:240a. (Abstr.)
8. Harkins, A. B., N. Kurebayashi, and S. M. Baylor. 1993. Resting my-
oplasmic free [Ca21] ([Ca2+]r) measured with fura red and fluo-3 in
intact single twitch fibers from frog skeletal muscle. Biophys. J. 64:
241a. (Abstr.)
9. Konishi, M., A. Olson, S. Hollingworth, and S. M. Baylor. 1988. My-
oplasmic binding of fura-2 investigated by steady-state fluorescence
and absorbance measurements. Biophys. J. 54:1089-1104.
10. Ottaway, J. H., and J. Mowbray. 1977. Compartmentation in control of
glycolysis. In Current Topics in Cellular Regulation. Vol 12. B. L.
Horecker and E. R. Stadtman, editors. Academic Press, Inc., New York.
107-208.
11. Baylor, S. M., and H. Oetliker. 1977. A large birefringence signal pre-
ceding contraction in single twitch fibres of the frog. J. Physiol. 264:
141-162.
12. Cantor, C. R., and P. R. Schimmel. 1980. Biophysical Chemistry. Part
II. W. H. Freeman and Co., San Francisco, 439-444.
13. De Mello, W. C. 1973. Membrane sealing in frog skeletal muscle fibers.
Proc. Natl. Acad. Sci. USA. 70:982-984.
14. Baylor, S. M., and H. Oetliker. 1975. Birefringence experiments on
isolated skeletal muscle fibres suggest a possible signal from the sar-
coplasmic reticulum. Nature (Lond.). 253:97-101.
15. Baylor, S. M., S. Hollingworth, C. S. Hui, and M. E. Quinta-Ferreira.
1986. Properties of the metallochromic dyes arsenazo III, antipyrylazo
III and azo 1 in frog skeletal muscle fibres at rest. J. Physiol. 377:89-
141.
16. Kushmerick, M. J., and R. J. Podolsky. 1969. Ionic mobility in muscle
cells. Science (Wash. DC). 166:1297-1298.
17. Poenie, M. 1990. Alteration of intracellular fura-2 fluorescence by vis-
cosity: a simple correction. Cell Calcium. 11:85-91.
18. Uto, A., H. Arai, and Y Ogawa. 1991. Reassessment of fura-2 and the
ratio method for determination of intracellular Ca21 concentrations.
Cell Calcium. 12:29-37.
19. Maylie, J., M. Irving, N. L. Sizto, and W. K. Chandler. 1987. Calcium
signals recorded from cut frog twitch fibers containing antipyrylazo III.
J. Gen. Physiol. 89:83-143.
20. Baylor, S. M., and S. Hollingworth. 1988. Fura-2 calcium transients in
frog skeletal muscle fibres. J. Physiol. 403:151-192.
21. Crank, J. 1956. The Mathematics of Diffusion. Oxford University Press,
London. 347 pp.
22. Blinks, J. R., R. Rudel, and S. R. Taylor. 1978. Calcium transients in
isolated amphibian skeletal muscle fibres: detection with aequorin. J.
Physiol. 277:291-323.
23. Baylor, S. M., M. W. Marshall, and W. K. Chandler. 1982. Dichroic
components of Arsenazo III and Dichlorophosphonazo III signals in
skeletal muscle fibres. J. Physiol. 331:179-210.
24. Raju, B., E. Murphy, L. A. Levy, R. D. Hall, and R. E. London. 1990.
A fluorescent indicator for measuring cytosolic free magnesium. Am.
J. Physiol. 256:C540-C548.
25. Konishi, M., S. Hollingworth, A. B. Harkins, and S. M. Baylor. 1991.
Myoplasmic calcium transients in intact frog skeletal muscle fibers
monitored with the fluorescent indicator furaptra. J. Gen. Physiol. 97:
271-301.
26. Baylor, S. M., S. Hollingworth, C. S. Hui, and M. E. Quinta-Ferreira.
1985. Calcium transients from intact frog skeletal muscle fibres simul-
taneously injected with antipyrylazo III and azo 1. J. Physiol. 365:70P.
27. Klein, M. G., B. J. Simon, G. Szucs, and M. F. Schneider. 1988. Si-
multaneous recording of calcium transients in skeletal muscle using
high- and low-affinity calcium indicators. Biophys. J. 53:971-988.
28. Cannell, M. B., and D. G. Allen. 1984. Model of calcium movements
during activation in the sarcomere of frog skeletal muscle. Biophys. J.
45:913-925.
29. Hodgkin,A. L., and P. Horowicz. 1960. Potassium contractures in single
muscle fibres. J. Physiol. 153:386-403.
30. Godt, R. E., and B. D. Lindley. 1982. Influence of temperature upon
contractile activation and isometric force production in mechanically
skinned muscle fibers of the frog. J. Gen. Physiol. 80:279-297.
31. Kurebayashi, N., and Y Ogawa. 1988. Imcrease by trifluoperazine in
calcium sensitivity of myofibrils in a skinned fibre from frog skeletal
muscle. J. Physiol. 403:407-424.
32. Brozovich, F V., L. D. Yates, and A. M. Gordon. 1988. Muscle force
and stiffness during activation and relaxation. J. Gen. Physiol. 91:399-
420.
